Fulltext

Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication

Stotz, M. ; Thümmler, D. ; Schürch, M. ; Renggli, J.-C ; Urwyler, A. ; Pargger, H.

In: British Journal of Anaesthesia, 2004, vol. 93, no. 6, p. 868-871

Ajouter à la liste personnelle
    Titre
    • Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication
    Auteur
    • Stotz, M.. Department of Anaesthesia
    • Thümmler, D.. Department of Surgery and
    • Schürch, M.. Department of Anaesthesia, Kantonsspital Aarau, CH-5001 Aarau, Switzerland
    • Renggli, J.-C. Department of Surgery and
    • Urwyler, A.. Department of Anaesthesia
    • Pargger, H.. Division of Operative Critical Care, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland and
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • British Journal of Anaesthesia, 2004, vol. 93, no. 6, p. 868-871. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:296712
    Summary
    Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases